Top Markets
Coin of the day
Scandinavian Medical Solutions A/S Scandinavian Medical Solutions A/S

Scandinavian Medical Solutions A/S

SMSMED
Clasificación en acciones #31630
Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018... Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018 and headquartered in Aalborg, Denmark, specializes in medical imaging equipment. The company provides a comprehensive array of diagnostic and therapeutic devices, encompassing CATH lab systems, CT scanners, linear accelerators, mammography units, PET/CT and SPECT/CT systems, X-ray machines, ultrasound equipment, MRI scanners, GAMMA/SPECT systems, C-arms, mobile X-ray units, R/F systems, and DEXA scanners, among others. Furthermore, SMS supplies critical spare parts for specific equipment types including CT, MRI, CATH lab, X-ray, mammography, PET/CT, and C-arm systems. Beyond sales, their offerings extend to equipment rental and technical support services. SMS serves a broad clientele, including hospitals, various medical clinics, and distributors worldwide.
Precio por acción
$0.4636168
Capitalización bursátil
$12.89M
Cambio (1 día)
-1.68%
Cambio (1 año)
-29.90%
País
DK
Comercio Scandinavian Medical Solutions A/S (SMSMED)

Categoría

Ingresos de Scandinavian Medical Solutions A/S (SMSMED)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Scandinavian Medical Solutions A/S, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Scandinavian Medical Solutions A/S desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
$6.51B -
US